Markus Wallner

2.1k total citations
61 papers, 965 citations indexed

About

Markus Wallner is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Markus Wallner has authored 61 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Markus Wallner's work include Cardiovascular Function and Risk Factors (14 papers), Diabetes Treatment and Management (12 papers) and Heart Failure Treatment and Management (10 papers). Markus Wallner is often cited by papers focused on Cardiovascular Function and Risk Factors (14 papers), Diabetes Treatment and Management (12 papers) and Heart Failure Treatment and Management (10 papers). Markus Wallner collaborates with scholars based in Austria, United States and Germany. Markus Wallner's co-authors include Dirk von Lewinski, Steven R. Houser, Deborah Eaton, Harald Sourij, Giulia Borghetti, Ewald Kolesnik, Huaqing Zhao, Remus M. Berretta, Peter P. Rainer and Burkert Pieske and has published in prestigious journals such as Circulation, Circulation Research and Scientific Reports.

In The Last Decade

Markus Wallner

57 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Wallner Austria	17	481	355	184	181	82	61	965
Μichael Spartalis Greece	17	295 0.6×	242 0.7×	234 1.3×	143 0.8×	78 1.0×	73	1.0k
Jun Huang China	16	417 0.9×	267 0.8×	201 1.1×	83 0.5×	73 0.9×	70	966
Suxin Luo China	21	363 0.8×	404 1.1×	159 0.9×	128 0.7×	158 1.9×	109	1.1k
Christian Hengstenberg Germany	20	242 0.5×	367 1.0×	216 1.2×	165 0.9×	88 1.1×	37	1.1k
Danny Guo Canada	8	551 1.1×	239 0.7×	104 0.6×	258 1.4×	47 0.6×	19	977
Mitsutoshi Oguri Japan	21	310 0.6×	436 1.2×	204 1.1×	166 0.9×	130 1.6×	93	1.2k
Subhash K. Das Canada	19	591 1.2×	412 1.2×	311 1.7×	189 1.0×	118 1.4×	27	1.4k
Holger H. Sigusch Germany	20	566 1.2×	287 0.8×	270 1.5×	94 0.5×	147 1.8×	46	1.2k
Hanjun Zhao China	15	377 0.8×	292 0.8×	274 1.5×	63 0.3×	123 1.5×	91	948
Zubair Shah United States	18	571 1.2×	242 0.7×	397 2.2×	124 0.7×	76 0.9×	84	1.2k

Countries citing papers authored by Markus Wallner

Since Specialization

Citations

This map shows the geographic impact of Markus Wallner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Wallner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Wallner more than expected).

Fields of papers citing papers by Markus Wallner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Wallner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Wallner. The network helps show where Markus Wallner may publish in the future.

Co-authorship network of co-authors of Markus Wallner

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Wallner. A scholar is included among the top collaborators of Markus Wallner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Wallner. Markus Wallner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoch, L., Bernhard Pfeifer, Sabrina Neururer, et al.. (2025). Assisted therapy optimizing module to improve physician adhErence with guideLine-directed medical heart failure therapy rationale and design of the AMPEL trial. IJC Heart & Vasculature. 61. 101797–101797.

Hatzl, Stefan, Andreas Reinisch, Albert Wölfler, et al.. (2025). Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score–Weighted Multicenter Study. Open Forum Infectious Diseases. 12(12). ofaf709–ofaf709.

Zach, David, Markus Wallner, Dirk von Lewinski, et al.. (2024). Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study. Journal of Clinical Medicine. 13(19). 5966–5966. 7 indexed citations

Zach, David, Alexander Peikert, Peter P. Rainer, et al.. (2024). The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure—A Prospective Study. Journal of Clinical Medicine. 13(7). 1930–1930. 5 indexed citations

Kolesnik, Ewald, Markus Wallner, Klemens Ablasser, et al.. (2024). Impact of the Timing of Mechanical Circulatory Support on the Outcomes in Myocardial Infarction-Related Cardiogenic Shock: Subanalysis of the PREPARE CS Registry. Journal of Clinical Medicine. 13(6). 1552–1552. 1 indexed citations

Benedikt, Martin, Faisal Aziz, Ewald Kolesnik, et al.. (2024). Impact of baseline ECG characteristics on changes in cardiac biomarkers and echocardiographic metrices after acute myocardial infarction treated with Empagliflozin. Scientific Reports. 14(1). 15083–15083. 1 indexed citations

Wallner, Markus, Davide Stolfo, Gianfranco Sinagra, et al.. (2024). Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries. European Heart Journal - Cardiovascular Pharmacotherapy. 10(4). 296–306. 3 indexed citations

Posch, Florian, Markus Wallner, Peter P. Rainer, et al.. (2023). Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort. European Journal of Internal Medicine. 118. 73–81. 2 indexed citations

Lewinski, Dirk von, Heiko Bugger, Ewald Kolesnik, et al.. (2023). Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort. Journal of Clinical Medicine. 12(22). 6988–6988. 2 indexed citations

10.

Lewinski, Dirk von, Ewald Kolesnik, Faisal Aziz, et al.. (2023). Timing of SGLT2i initiation after acute myocardial infarction. Cardiovascular Diabetology. 22(1). 269–269. 12 indexed citations

11.

Kern, Jan Marco, et al.. (2023). Lack of microbiological awareness on the ward as a key factor for inappropriate use of anti-infectives: results of a point prevalence study and user satisfaction survey in a large university hospital in Austria. Infection. 52(3). 995–1008. 2 indexed citations

12.

Kolesnik, Ewald, H. Maechler, Brigitte Pelzmann, et al.. (2022). miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium. International Journal of Molecular Sciences. 23(13). 6962–6962. 2 indexed citations

13.

Voglhuber, Julia, Michael Holzer, Snježana Radulović, et al.. (2022). Functional remodelling of perinuclear mitochondria alters nucleoplasmic Ca ²⁺ signalling in heart failure. Philosophical Transactions of the Royal Society B Biological Sciences. 377(1864). 1–99. 10 indexed citations

14.

Eaton, Deborah, Remus M. Berretta, Joshua G. Travers, et al.. (2022). Sex-specific responses to slow progressive pressure overload in a large animal model of HFpEF. American Journal of Physiology-Heart and Circulatory Physiology. 323(4). H797–H817. 7 indexed citations

15.

Lewinski, Dirk von, Martin Benedikt, Hannes Alber, et al.. (2022). Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction—The REC-DUT-002 Trial. Journal of Clinical Medicine. 11(19). 5728–5728. 2 indexed citations

16.

Eaton, Deborah, Thomas G. Martin, Senka Ljubojević-Holzer, et al.. (2022). HDAC Inhibition Regulates Cardiac Function by Increasing Myofilament Calcium Sensitivity and Decreasing Diastolic Tension. Pharmaceutics. 14(7). 1509–1509. 4 indexed citations

17.

Bergler‐Klein, Jutta, Peter P. Rainer, Markus Wallner, et al.. (2022). Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies. Wiener klinische Wochenschrift. 134(17-18). 654–674. 8 indexed citations

18.

Lucia, Claudio de, Markus Wallner, Deborah Eaton, et al.. (2018). Echocardiographic Strain Analysis for the Early Detection of Left Ventricular Systolic/Diastolic Dysfunction and Dyssynchrony in a Mouse Model of Physiological Aging. The Journals of Gerontology Series A. 74(4). 455–461. 56 indexed citations

19.

Kopp, Peter, Markus Wallner, Roland Reitsamer, et al.. (2018). Intraoperative Tumor Bed Boost With Electrons in Breast Cancer of Clinical Stages I Through III: Updated 10-Year Results. International Journal of Radiation Oncology*Biology*Physics. 102(1). 92–101. 20 indexed citations

20.

Wallner, Markus, Deborah Eaton, Remus M. Berretta, et al.. (2017). A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function. Scientific Reports. 7(1). 16587–16587. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact